MANALAPAN, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/COVD?src=hash" target="_blank"gt;#COVDlt;/agt;–College of Optometrists in Vision Development/Neuro-Optometric Rehabilitation Assoc. Issue Recommendation for O…
Author: Business Wire
Lumigan RC – Drug Insight, 2019-2021 with Historical & Forecasted Sales Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Lumigan RC – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Lumigan RC Drug Insight, 2019 highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of Lumigan RC covering the historical global sales and also provides the Lumigan RC sales estimation during the forecasted period (2019-2021). The report also covers the patents i
Two Thousand NuLids® Systems Sold
RANCHO SANTA FE, Cailf.–(BUSINESS WIRE)–New home use device for dry eye relief shows Dr and patient acceptance with 2,000 units sold.
UnitedHealthcare Vision Plans Again Rank Highest in Customer Satisfaction in J.D. Power Report
MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare Vision plans tied for highest in customer satisfaction among the nation’s vision carriers, according to J.D. Power.
Visioneering Technologies, Inc. Selects Positive Impact (Sales) Ltd. to Distribute NaturalVue Multifocal Lenses in the United Kingdom
ATLANTA–(BUSINESS WIRE)–Visioneering Technologies, Inc., has selected Positive Impact to distribute the NaturalVue Multifocal 1 Day Contact Lenses in the United Kingdom.
Conjunctivitis Therapeutics Markets, 2023 – Dominated by Akorn Incorporated, Allergan, Bausch Health, Novartis, and Santen Pharmaceutical – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Conjunctivitis Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The conjunctivitis therapeutics market will register a CAGR of over 8% by 2023. The ease of availability of antibiotic eye drops and ointments for the treatment of bacterial conjunctivitis and antibiotics for viral conjunctivitis is leading to an increase in the use of these therapeutics. The use of therapeutics is primarily to avoid the progression of t
Retinopathy – Global Partnering, 2012 to 2018 (2019 Update): Trends in Partnering Deals, Top Deals by Value – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Retinopathy Partnering 2012 to 2018” report has been added to ResearchAndMarkets.com’s offering. The report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. Trends in partnering deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides an analysis of partnering deals. The majority of deals are discovery or devel
Omeros Corporation Appoints Thomas F. Bumol, Ph.D., to Board of Directors
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER) today announced the appointment of Thomas F. Bumol, Ph.D., to its Board of Directors. Dr. Bumol is Executive Director of the recently established Allen Institute for Immunology and former long…
BostonSight® Promotes Sara Yost to CEO
NEEDHAM, Mass.–(BUSINESS WIRE)–BostonSight, an international leader in the treatment of patients with complex corneal disease, today announced that its CFO, Sara Yost, will be promoted to CEO effective March 11, 2019. She will replace current Preside…
STAAR Surgical Announces Strategic Cooperation Agreement With the Smile Eyes Group in Germany and Austria
MONROVIA, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced a Strategic Cooperation Agreement with the Smile …
Pr3vent, Inc. Completes Series A Financing Led By InFocus Capital Partners
PALO ALTO, Calif.–(BUSINESS WIRE)–Series A financing accelerates development of Pr3vent’s breakthrough artificial intelligence eye screening tool for newborns.
GenSight Biologics annonce la publication de résultats de tolérance positifs de l’étude de Phase I/II de GS010 dans le JAMA Ophthalmology
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée à la découverte et au développement de thérapies gé…
GenSight Biologics Announces Publication of Positive Safety Data from Phase I/II Trial of GS010 in the JAMA Ophthalmology
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central …
Worldwide Intraocular Lenses (IOL) Market Report, 2019 – Alcon, Bausch + Lomb and J&J Vision Care are Dominating – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Intraocular Lenses – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Intraocular Lenses i
Topcon Healthcare Solutions and Oculo Form Global Partnership
OAKLAND, N.J. & MELBOURNE, Australia–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/oculo?src=hash" target="_blank"gt;#oculolt;/agt;–Topcon Healthcare Solutions and Oculo Form Global Partnership, Joining Forces to Adv…
Technology Leader in Optical and Ophthalmology Cloud Solutions, KIDE Systems, Becomes Topcon Healthcare Solutions EMEA
HELSINKI–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/topcon?src=hash" target="_blank"gt;#topconlt;/agt;–KIDE Systems announces new branding, Topcon Healthcare Solutions EMEA (THS EMEA), as part of the Topcon Corporation.
OMEICOS Therapeutics Strengthens Board of Directors with the Appointment of Christian Schetter
BERLIN & BOSTON–(BUSINESS WIRE)–OMEICOS Therapeutics, a biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases, today announced the appointment of Christian Schetter, Ph.D., as an independent Board Member. Christian has over 20 years’ industry experience across the life sciences sector, and most recently joined venture capital firm Arix Bioscience plc as an Entrepreneur in Residence. Before tha
Resumen: En febrero, Eyenuk proporcionará pruebas oculares basadas en inteligencia artificial (IA) a miles de italianos a través de una colaboración con el Centro Ambrosiano Oftalmico
LOS ÁNGELES–(BUSINESS WIRE)–Eyenuk Inc., proveedor global de tecnologías y servicios médicos basados en inteligencia artificial (IA), y líder en aplicaciones reales para la tecnología AI Eye Screening™, ha anunciado hoy…
Eyenuk bietet Tausenden von Italienern durch die Zusammenarbeit mit dem Centro Ambrosiano Oftalmico (CAMO) im Februar eine Augenuntersuchung mittels künstlicher Intelligenz (KI)
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., ein weltweit tätiges Unternehmen für Medizintechnik und medizinische Dienstleistungen im Bereich künstliche Intelligenz (KI) sowie Marktführer im Hinblick auf die Anwendung des AI Eye Scree…
Eyenuk propose au mois de février à plusieurs milliers d’Italiens un dépistage oculaire basé sur l’intelligence artificielle (IA), via une collaboration avec l’Ambrosian Ophthalmic Center
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., société mondiale de technologies et services médicaux basés sur l’intelligence artificielle (IA), qui se démarque en tant que leader dans le domaine des applications en…